GLP-1 Agonists Reimagined: The Tripartite Applications of the Semaglutide Hormone

Joon Daniel Park, Merajur Rahman and Jeffrey Ye
Additional contact information
Joon Daniel Park: Northern Valley Regional High School at Old Tappan, 100 Central Ave, Old Tappan, NJ 07675, United States
Merajur Rahman: The Bronx High School of Science, 75 W 205th St, Bronx, NY 10468, United States
Jeffrey Ye: Francis Lewis High School, 58-20 Utopia Pkwy, Fresh Meadows, NY 11365, United States

Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990, 2025, vol. 13, 212-226

Abstract: Semaglutide, a GLP-1 receptor agonist has been initially adopted as a treatment and regulator for the Type 2 Diabetes disease. In this essay, we will be focusing on the three primary roles that the semaglutide fulfills throughout day to day life or in potential real world applications. We examined different hormones related to the endocrine system, and identified differences in weaknesses and strengths between GLP-1 and semaglutide. We also assessed the different roles that semaglutide may be used for. The original intended use being Type 2 Diabetes regulation, where we established the utilization of the potent insulin releasing trait of semaglutide being the key factor for Type 2 Diabetes regulation. A repurposed use for weight reduction, where we identified the secondary symptoms of insulin release such as lower appetite. Finally, a speculative application where the diabetes regulation capabilities may have a positive correlation in affecting neurological diseases such as dementia. Through the compilation and review of historic and recent sources, this paper highlights the broader usage of the semaglutide compound. The findings suggest that semaglutide’s mechanisms and variety makes it a promising candidate for future metabolic and potentially groundbreaking neurological medicine.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://techniumscience.com/index.php/biochemmed/article/view/13309 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:tec:bioche:ojs:13309

DOI: 10.47577/biochemmed.v13i.13309

Access Statistics for this article

Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 is currently edited by Anna Maria Golita

More articles in Technium BioChemMed: Journal of Multidisciplinary Research, Biology, Chemistry and Medicine ISSN 2734 - 7990 from Technium Science
Bibliographic data for series maintained by Anna Maria Golita ().